Abstract
Cleft lip and/or palate (CL/P) are common anomalies occurring in 1/800 live-births. Pathogenic SPECC1L variants have been identified in patients with CL/P, which signifies a primary role for SPECC1L in craniofacial development. Specc1l mutant mouse embryos exhibit delayed palatal shelf elevation accompanied by epithelial defects. We now posit that the process of palate elevation is itself abnormal in Specc1l mutants, due to defective remodeling of palatal mesenchyme. To characterize the underlying cellular defect, we studied the movement of primary mouse embryonic palatal mesenchyme (MEPM) cells using live-imaging of wound-repair assays. SPECC1L-deficient MEPM cells exhibited delayed wound-repair, however, reduced cell speed only partially accounted for this delay. Interestingly, mutant MEPM cells were also defective in coordinated cell movement. Therefore, we used open-field 2D cultures of wildtype MEPM cells to show that they indeed formed cell streams at high density, which is an important attribute of collective movement. Furthermore, activation of the PI3K-AKT pathway rescued both cell speed and guidance defects in Specc1l mutant MEPM cells. Thus, we show that live-imaging of primary MEPM cells can be used to assess mesenchymal remodeling defects during palatal shelf elevation, and identify a novel role for SPECC1L in collective movement through modulation of PI3K-AKT signaling.
Subject terms: Mechanisms of disease, Cell migration, Time-lapse imaging, Disease model
Introduction
Development of secondary palate involves coordinated growth and movement of palatal shelves in conjunction with surrounding craniofacial structures1–3. In mice, the palatal shelves originate as a pair of vertical outgrowths from the maxillary processes at embryonic-day 11.5 (E11.5) and extend downward adjacent to the tongue until E13.51. By E14.5, the palatal shelves elevate to position themselves horizontally above the tongue and extend toward the midline. By E15.5, the shelves have adhered and fused at the midline to form the secondary palate. Defects in palatal shelf outgrowth, elevation, or fusion can lead to cleft palate, one of the most common human birth defects1,4. Among these steps, elevation is the most poorly understood. Histological studies of palate elevation have shown that the mechanism differs along the anteroposterior axis1,5,6. The anterior palate exhibits a “flipping-up” motion where the distal ends of the shelves rise toward the midline. In contrast, the middle and posterior sections of the palate undergo more extensive remodeling, wherein the medial walls of the shelves extend horizontally as the distal ends of the shelves retract, creating a “bulge”5–7. This latter process can be referred to as mesenchymal remodeling5. Interestingly, the “bulging” appears to occur first, indicating it may be the driving event during elevation6.
Several cellular mechanisms for mesenchymal remodeling during palate elevation have been proposed1,2,8,9. Cell proliferation is required, but not sufficient, for elevation to occur10–12. Organ culture of palatal shelf explants have shown that palatal mesenchyme also has migratory properties, potentially guided by WNT5A and FGF10 chemotactic gradients13. Thus, coordinated movement of the palatal mesenchyme may contribute to palate remodeling, however, collective migration attributes have not been investigated in palate mesenchymal cells.
SPECC1L is a cytoskeletal protein that associates with both filamentous actin and microtubules14. Mutations in SPECC1L have been identified in multiple patients with craniofacial malformations, including cleft palate14–17. Thus far, these mutations have been autosomal dominant nonsynonymous variants that cluster in the second coiled-coil (CCD2) and the C-terminal calponin homology (CHD) domains15. Mouse embryos homozygous for a null Specc1l gene-trap allele die between E9.5 and E10.5 with open neural-folds and defects in cranial neural crest cell delamination18. In cultured U2OS osteosarcoma cells, loss of SPECC1L results in poor cell migration in wound-repair assays14, increased filamentous actin staining14,18, and at high cell-density, cell-shape change and abnormal staining of adherens junction markers β-catenin and E-cadherin18. We have recently reported generation of a new gene-trap allele (Specc1lcGT), and a Specc1l-truncation allele lacking 510 C-terminal amino acids (Specc1l∆C510) that removes the CHD. Homozygous mutants for Specc1lcGT are embryonic lethal, while those for Specc1lΔC510 are perinatal lethal19. Crossing these alleles resulted in Specc1lcGT/∆C510 compound heterozygous mutant embryos that were also perinatal-lethal and exhibited a delay in palate elevation as well as oral epithelial defects19. In particular, we reported the presence of transient oral epithelial adhesions between palatal shelf and tongue or buccal surfaces, and ectopic expression of adhesion molecules at the apical surface of the palate periderm layer19. As SPECC1L is broadly expressed in both palate epithelium and mesenchyme, we hypothesized that it may also play a role during mesenchymal remodeling.
In this study we used quantitative analyses of motility to show that primary mouse embryonic palatal mesenchyme (MEPM) cells exhibit stream formation, an attribute of collective migration, and showed that this behavior is impaired in Specc1l-mutant MEPM cells. We also performed wound-repair experiments using primary MEPM cells from Specc1lcGT/∆C510 mutant embryos to show defects in both cell speed and directionality. Importantly, we show that pharmacological activation of the PI3K-AKT pathway, which is reduced in Specc1l mutants, is sufficient to rescue speed and directionality defects in these cells. Together, these data show a novel role for SPECC1L in collective cell movement through regulation of PI3K-AKT signaling pathway, as well as establish MEPM cells as a proxy model to study mesenchymal remodeling defects during palate elevation.
Materials and methods
MEPM isolation and cell culture
Specc1lΔC510/+ × Specc1lcGT/+ mouse mating-pairs were placed together overnight, and the gestational stage was defined as E0.5 at noon on the day plug was identified. Females were euthanized at E13.5, and embryos were harvested in 1× PBS. Palatal shelves were dissected away from the oral cavity under aseptic conditions, placed in a 1.5 mL tube with 0.5 mL of 0.25% Trypsin (ThermoFisher, 25200056), and incubated at 37 °C for 10 min. Occasional pipetting was performed to accelerate mechanical dissociation. The trypsinized MEPM cells were mixed with 5 mL of high-glucose DMEM (HyClone, SH30243.01) containing 10% FBS (Corning, 35-010-CV) in a conical tube. The tube was centrifuged at 200rcf for 5 min to pellet the cells. MEPM cells were resuspended in fresh DMEM containing 10% FBS, plated on tissue-culture treated plastic dishes, and incubated at 37 °C. Following expansion, cells were cryopreserved, and only passaged up to 3 times for use in experiments. All experiments involving animals were carried out with a protocol approved by the KUMC Institutional Animal Care and Use Committee, in accordance with their guidelines and regulations.
U2OS cell culture
Control and SPECC1L-kd U2OS cells were generated previously from U2OS osteosarcoma cells (ATCC HTB-96) as reported14. U2OS cells were cultured in DMEM (HyClone, SH30243.01) containing 10% FBS (Corning, 35-010-CV) as shown previously18.
PI3K-AKT pathway activator treatment
For PI3K-AKT pathway small-molecule activation experiments, 100 µg/mL 740Y-P (ApexBio, B5246) was added 24 h prior to imaging. The activator containing medium was refreshed at the onset of imaging, and it remained throughout the duration of the experiment (48 h). An equal proportion of water was added as vehicle to control wells.
Live-cell imaging
Imaging was performed using the EVOS FL Auto Imaging System (ThermoFisher, AMAFD1000) with the EVOS Onstage Incubator (ThermoFisher, AMC1000). Cell cultures were kept in a humidified, 5% CO2 environment at 37 °C over a period of 48–72 h. Phase contrast images were collected at × 4 or × 10 magnification, every 10 or 20 min.
Image processing
To detect cell-occupied area, a global threshold was applied to the local standard deviation of image brightness following the procedures outlined in Neufeld, et al.20. The code is available at http://github.com/aczirok/cellconfluency. Cell motility was extracted using our particle image velocimetry (PIV) algorithm, with an initial window size of 50 µm21,22, resulting in a velocity field v(x,t) for each frame t and image location x. The average speed of cell motility was extracted from v(x,t) as a spatial average over the cell-occupied area.
Wound-repair assay
For wound-repair assays, MEPM and U2OS cells were seeded at superconfluent densities of 1400/mm2 and 2300 cells/mm2 (respectively) into silicone inserts (Ibidi, 81176) in 35 mm diameter tissue culture dishes. These silicone inserts provide 500 µm wide cell-free gaps. Live-imaging started at the removal of the silicone insert, 48 h after cell attachment (56 h after seeding). For each wound, 4–5 non-overlapping fields were recorded every 10 min at × 10 objective magnification. Image sequences were evaluated by compiling confluency data A(t)—the size of cell-occupied area normalized to the field of view, as a function of time. The speed of wound-closure was established as V = (w/2) (dA/dt), where w denotes the width of the field.
Spontaneous collective motility assay
For the analysis of general stream formation and collective motility of MEPM cells, we first estimated the effective density of cells migrating into the wound. This density of cells migrating into the wound along the cell-front after 14-h of migration was approximately 600 cells/mm2. Therefore, we started by seeding cells at a lower density of 300 cells/mm2, allowed them to grow for 20 h, and then live-imaged these cells for 30 additional hours. This time-frame allowed us to capture the desired “high” density of 600 cells/mm2 that we found in the migratory cell-front of wound assays. We then seeded cells at densities of 100 cells/mm2 (“medium”) and 30 cells/mm2 (“low” or individual cells) for comparison. MEPM cells were seeded at low (30/mm2), medium (100/mm2), and high (300/mm2) densities into 3D-printed 6 mm diameter rings on 35 mm tissue culture dishes23. Following overnight growth, cultures were live-imaged every 10 min with a 4× phase contrast objective for and additional 30 h.
Local spatial correlations of cell movements were characterized by the average flow field that surrounds moving-cells as described previously24,25. Briefly, a reference system was aligned to each vector v(x,t) and their “neighbors” registered in the appropriate bin (front, rear, etc.). The average velocity vector (U) in each bin is indicative of spatial correlation: the average of random vectors is close to zero, while it is non-zero when velocities share a common component. The calculated U(x) flow field was fitted with an exponential function U(x) = a*exp(− x/ × 0) + U0, where × 0 is the correlation length: the characteristic distance at which local velocity–velocity correlations disappear.
Nuclear orientation assay
To quantitatively characterize local orientational ordering of mesenchyme nuclei, we performed the following image analysis sequence: (1) DAPI-labeled frozen sections were imaged with × 20 objective magnification. (2) After loading the images into ImageJ26, the palatal shelf area was delineated, then nuclei were segmented by brightness-based global thresholding. (3) Touching nuclei in the binary segmented image were resolved by a watershed transformation. (4) Segmented clusters larger than 10 pixels were identified and fitted with an ellipse. (5) Nuclei with an unambiguous orientation (the ratio of the minor and major ellipse axes being less then 0.8) were assigned into cells of a spatial grid with a cell size of 50 um. (6) In each cell, we calculated the scalar 2D nematic order parameter27 as , where theta () is the angle between the long axis of the ellipse and a reference direction, and the averages are calculated for each nucleus within the grid cell. The order parameter S = 1 indicates a configuration in which nuclei are completely parallel, while S = 0 indicates a completely random set. Intermediate numbers 0 < S < 1 indicate various degrees of partial ordering. Using the same data, we also calculated the direction of the local prevailing order. (7) We used the same measures to compare regions within the palatal shelves by pooling the segmented nuclei from multiple specimens into three spatial domains (lingual, buccal and hinge).
Analysis of individual cell-trajectories
Individual cells were tracked manually on consecutive images (github/donnagreta/cm_track) yielding positions P(i,t) of cell i at time t. Motivated by a similar analysis performed by Biggs et al.28, trajectories were characterized by the total path-length net displacement into the wound D(i,t) =|X(i,t)-X(i,0)|, where X is the projection of P in the direction perpendicular to the wound. Guidance efficiency was calculated as D(i,t)/T(i,t) for each cell i and timepoint t. Cultures were characterized by the population average of these single cell measures, evaluated at a suitable timepoint t.
Statistical analysis
To establish statistical significance, we calculated the quantitative measure for each independent sample (time-lapse recording, physical section of an embryo). The sets, containing at least 4 independent values, were compared by two-tailed Welch t-tests, which does not assume equal variance or paired data. For the calculations we used the scipy.stats.ttest_ind function of the python programming language.
Results
Specc1lcGT/ΔC510 mutant embryos show abnormal palatogenesis
Specc1lcGT/ΔC510 compound heterozygotes are perinatal lethal and show a delay in palate elevation at E14.519. However, palatal shelves in most mutants recover and fuse by E15.5 (Fig. 1)19. Analysis of E14.5 sections at mid-palate region indicated that the tongue in the mutant is usually adequately depressed, but the palatal shelves are acutely angled and do not immediately move inwards to occupy the space above the tongue (Fig. 2)19. Importantly, palate elevation in these mutants follows an abnormal sequence where posterior palate advances prior to middle and anterior palates, as in wildtype (WT) embryos (Fig. 1b vs. e). Given the delayed and abnormal palate elevation in Specc1lcGT/ΔC510 mutants, we hypothesized that (a) this delay is due to poor mesenchymal remodeling during elevation, and (b) coordinated movement of palatal mesenchyme cells is required for efficient remodeling. To determine the role of SPECC1L in the mesenchymal remodeling during palate elevation, we decided to perform in vitro motility assays using primary mouse embryonic palatal mesenchyme cells (MEPM) from WT and Specc1lcGT/ΔC510 compound heterozygous embryos.
Specc1l-deficient mouse embryonic palatal mesenchyme (MEPM) cells show migration defects during wound-closure
We previously reported that SPECC1L-deficient U2OS osteosarcoma cells showed poor migration in wound-repair assays14. To determine if MEPM cells from Specc1lcGT/ΔC510 compound heterozygous embryos showed similar defects, we live-imaged wound-repair assays at superconfluent cell densities (Suppl. Movie 1). As representative images of time-lapse recordings indicate (Fig. 3a–f), mutant MEPM cells (Fig. 3d–f) take longer to close the wound than WT cells (Fig. 3a–c). This effect was quantified by image-analysis measures of confluency (Fig. 3g), from which a 33% reduction in the average speed of wound-fronts, from 6 to 4 µm/h, could be established (Fig. 3i). We used PIV analysis to quantify overall cell-motility within the entire microscopic field. The analysis indicated that MEPM cells remained motile even after closure of the wound (Fig. 3h), and the overall motile activity of Specc1lcGT/ΔC510 mutant MEPM cells was reduced by 20%, from 4.4 to 3.5 µm/h (Fig. 3i).
To identify motility defects at the level of individual cells, 40 WT and 40 Specc1lcGT/ΔC510 mutant MEPM cells were tracked manually as they moved into the wound. Cell trajectories of Specc1lcGT/ΔC510 mutant MEPM cells (Fig. 4a,b) indicated a larger deviation perpendicular to the direction of wound-closure, hence a less-efficient guidance into the wound. Each trajectory was characterized at various timepoints during wound-closure by: (1) the length of total distance migrated (Fig. 4c, solid lines), (2) the net displacement into the wound (Fig. 4c, dashed lines), and (3) the ratio of these two distances as a measure of guidance efficiency (Fig. 4d). While these quantities did not indicate a sudden change in cell behavior, the guidance efficiency of WT MEPM cells improved by ~ 50% during the first 10 h of the wound-closure process (Fig. 4d). Compared to these WT measures, the Specc1lcGT/ΔC510 mutant MEPM cells exhibited a 25% reduction in total distance migrated, and a larger 30% reduction in the net displacements into the wound (Fig. 4c). The larger reduction in directed motility is associated with consistently poor guidance efficiency of mutant MEPM cells (Fig. 4d). Distribution of the three motility measures within the tracked-cell population is quite broad (Fig. 4e). The most conspicuous difference between WT and Specc1lcGT/ΔC510 mutant cultures is the presence of an unguided cell population within the latter (Fig. 4e, green circle). Thus, population-level measures as well as analysis of individual trajectories indicate a substantial role of SPECC1L in both promoting MEPM migration and responding to guidance cues.
MEPM cells display attributes of collective movement
Since our analysis of wound-repair live-imaging studies indicated that Specc1lcGT/ΔC510 mutant cells had defects in speed and guidance, we asked a more fundamental question: do WT MEPM cells display attributes of collective movement? To test this, we recorded WT and Specc1lcGT/ΔC510 mutant MEPM cells in a simple two-dimensional tissue-culture environment (Fig. 5a–c, WT cells; Suppl. Movie 2). We use the cell-front density in the wound of ~ 300 cells/mm2 as reference (“high”), and included two lower cell densities of 100 cells/mm2 (“medium”) and 30 cells/mm2 (“low” or individual cells) for comparison. Interestingly, only when cultured at high density, MEPM cells created ordered and long-range oriented domains reaching up to 1 mm (Fig. 5c). While we could not perform live-imaging at such resolution in embryos, we looked at E13.5 embryonic tissue sections (Fig. 2a,b) for evidence of alignment of palatal shelf mesenchymal cells. We used nuclear shape and orientation as a proxy marker for orientation of the spindle-shaped mesenchymal cells (Fig. 6a,b), and found that palatal shelf mesenchymal cells tend to be aligned with their neighbors (Fig. 6c), consistent with our findings of stream-formation in cultured MEPM cells. In particular, we found that the prevailing orientation of the nuclei is parallel with the vertical axis of the E13.5 palatal shelf (Fig. 6d). The buccal region, however, exhibits a significant orientation toward the tongue at E13.5, just prior to the elevation of the palatal shelves (Fig. 6d). Thus, cultured MEPMs at high density appear ordered similarly to the in vivo palatal mesenchyme.
Analysis of spontaneous MEPM cell motility by PIV analysis, revealed a sustained motile behavior despite the high cell density (Fig. 5d). The average motile speed was not significantly different between WT and mutant cultures (Fig. 5e, ~ 4 µm/h), in contrast to PIV cell speeds observed in wound-repair experiments (Fig. 3i). Trajectories of individually tracked cells revealed a cell-density-dependent ordering (Suppl. Movie 3): cell trajectories of adjacent cells in low-density cultures appeared uncorrelated (Fig. 5f, WT cells), while those in high-density cultures were largely parallel (Fig. 5g, WT cells).
To quantify this apparent collective motion of MEPM cells at high density, we adopted a spatial cross-correlation measure24,25, which determined the average co-movement speed of cells at various locations (e.g., front, rear, left, right) relative to a moving cell (Fig. 7a–d). Correlation between cell movements was higher when cells were in close vicinity and gradually tapered off as distance increased beyond 300 µm (Fig. 7e,f). This effect was quantified by fitting the co-movement speed profiles with an exponential function, yielding the correlation length as a fitted parameter. Correlation length values indicated a 33% reduction, only at high density, in both the parallel and perpendicular correlation lengths of Specc1lcGT/ΔC510 mutant MEPM cells when compared with WT MEPM cells. This reduction in correlated movement at high cell-densities (Fig. 7g) suggests an impaired ability of mutant cells to form streams.
Collective movement, especially in mesenchymal cells, requires active cell–cell communication involving cell-adhesion molecules, as well as dynamic reorganization of the cytoskeleton to direct movement in response to signals from neighboring cells24,29,30. The more pronounced correlation in movement seen in high-density MEPM cultures is consistent with this contact-dependent mechanism. To further support this contact-dependent mechanism, we looked at both expression of adhesion molecules that are involved in collective movement of mesenchymal cells such as the neural crest, as well as reorganization of the actin cytoskeleton during migration. Using a previously published primary MEPM RNAseq dataset31, we were able to identify robust expression of all major adhesion molecules identified to be involved in collective migration of mesenchymal cells32. These molecules include N-cadherin, RhoA, Rac1, Cdc42, as well as components of Robo/Slit and Eph/EphR signaling (Suppl. Table S1). We also confirmed the presence of cadherins in primary MEPM cells at the protein level, using a pan-Cadherin antibody (Suppl. Fig. S1). Similar to other cell types, primary MEPM cells during migration also organized their actin filaments perpendicular to the direction of migration (Suppl. Fig. S2). Consistent with our previous U2OS data14, fewer mutant cells reorganized their actin filaments adequately (Suppl. Fig. S2). Thus, our data indicate that cultured MEPM cells have an innate ability to move collectively.
Upregulation of PI3K-AKT signaling rescues Specc1l-deficient migration defects
We previously reported that loss of SPECC1L results in decreased PI3K-AKT signaling along with defects in cell-adhesion and cell-shape18. Pharmacological activation of the pathway was sufficient to rescue these phenotypes18. To test if PI3K-AKT pathway activation could also rescue wound-closure defects in mutant MEPM cells, we repeated the wound-closure experiments reported in Fig. 2 in the presence and absence of 740Y-P (100 µg/mL), a peptide activator of PI3K (Fig. 8). We found that activation of PI3K-AKT pathway did indeed rescue the wound-closure defect in Specc1lcGT/ΔC510 mutant MEPM cultures (Fig. 8a). Specifically, 740Y-P treatment increased the rate of wound-closure in both WT and Specc1lcGT/ΔC510 mutant MEPM cultures by almost twofold (Fig. 8c), even beyond the rate observed in untreated WT MEPM cultures. Interestingly, PIV analysis of 740Y-P treatment did not show an increase in overall WT cell motility, and only a 20% increase in Specc1lcGT/ΔC510 mutant cell motility (Fig. 8b,c). Therefore, we hypothesized that improved cell-guidance into the wound contributed to the improved wound-closure in mutant cultures treated with 740Y-P.
To determine if cell-guidance was improved in the rescue experiments, we compared the trajectories of individual MEPM cells from treated and untreated cultures (Fig. 8d). The dispersion of Specc1lcGT/ΔC510 mutant cells perpendicular to the direction of wound-closure was visibly reduced by PI3K activation, indicating improved guidance into the wound. Statistical evaluation of individual cell-trajectories (Fig. 8e–h) revealed a 40% increase in the total distance migrated (Fig. 8e,h), a twofold increase in the net displacement directed into the wound (Fig. 8f,h), and a 66% increase in guidance efficiency (Fig. 8g,h) in 740Y-P treated Specc1lcGT/ΔC510 mutant MEPM cells. Taken together, the data indicate that PI3K activation can rescue SPECC1L deficiency-related motility defects by improving both cell motility speed and guidance efficiency.
SPECC1L-dependent collective migration in other cell types
SPECC1L deficiency has been previously shown to result in defects in cell migration in cultured U2OS cells14,18. To support a primary role of SPECC1L in collective cell migration, we analyzed time-lapse imaging of control and SPECC1L-kd U2OS cells in wound-repair assays, similarly to the MEPM data. We were able to show again in U2OS cells that SPECC1L deficiency resulted in slower wound-closure coupled with poor stream-formation and directional movement (Suppl. Fig. S3). We also confirmed that activation of the PI3K-AKT pathway rescued the cell speed and guidance defects in SPECC1L-kd U2OS cells (Suppl. Fig. S4). Interestingly, in contrast to WT MEPM cells, control U2OS cells did not exhibit a significant effect following PI3K-AKT pathway activation. This lack of a marked response likely reflects that U2OS is a cancer cell line with an intrinsically higher than normal level of PI3K-AKT signaling33–35. Taken together, these findings point to a common role of SPECC1L in the regulation of cell motility and guidance.
Discussion
Studies of palatogenesis have demonstrated that remodeling from vertical to horizontal direction is a primary feature of the elevation process3,6,36. This remodeling is likely initiated by the medial edge epithelium of the palatal shelf, but driven by the palate mesenchyme. While primary MEPM cells have been used for testing the effect of various inhibitory compounds, growth factors, and gene-expression changes31,37–42, only a few studies have investigated the migration of MEPM cells39,43,44, and none, to our knowledge, have examined if they can migrate collectively. We identify the presence of stream formation in MEPM cells, a behavior generally considered to be a feature of collective movement24,25,45.
We also show that SPECC1L deficiency impaired the ability of palatal mesenchyme cells to move collectively—a result that we posit partially explains the observed delayed and abnormal palate elevation in Specc1lcGT/ΔC510 mutants (Fig. 1)19. The defect in collective migration was also validated in U2OS cells, an independent cell line, which strongly supports a primary role for SPECC1L in collective movement.
We previously showed that SPECC1L deficiency leads to reduced PI3K-AKT signaling, and that PI3K-AKT activation was able to rescue cell-shape and cell-adhesion phenotypes in SPECC1L-kd U2OS cells18. Our analyses now show that activation of PI3K-AKT signaling rescued both cell speed and directionality defects during wound-closure of Specc1lcGT/ΔC510 mutant MEPM cells, as well as in SPECC1L-kd U2OS cells. We have shown previously that SPECC1L deficiency leads to a reduction in total AKT levels, rather than just activated phospho-AKT18. This reduction in total AKT is at the protein level as RNA levels do not change18. Several processes have been identified that play a role in AKT stability, including ubiquitin proteasome-dependent pathway, caspase-mediated cleavage, and caspase-dependent ubiquitination46. AKT is known to require translocation to the cell membrane for full activation47–49. Thus, it is possible that SPECC1L deficiency affects one or more of these processes involved in AKT stability, resulting in increased AKT degradation. Taken together, our results are consistent with a pro-migratory role for AKT50 and suggest that SPECC1L regulates cell migration through PI3K-AKT signaling.
This study represents the first depiction of collective movement characteristics in cultured MEPM cells, and supports the hypothesis that palate elevation involves collective movement of the mesenchyme. In addition to our Specc1l mutants, there remain several mouse mutants with elevation defects for which the underlying pathogenic mechanisms have not been fully elucidated1,8,9,51. Future analysis of these mutants may benefit from using primary MEPM cell migration as a proxy for mesenchymal remodeling during palatal shelf elevation.
Supplementary Information
Acknowledgements
This project was supported in part by the National Institutes of Health Grants DE026172 (I.S.), GM102801 (A.C.), and F31 DE027284 (E.H.). I.S. was also supported in part by the Center of Biomedical Research Excellence (COBRE) Grant (National Institute of General Medical Sciences P20 GM104936), Kansas IDeA Network for Biomedical Research Excellence grant (National Institute of General Medical Sciences P20 GM103418), and Kansas Intellectual and Developmental Disabilities Research Center (KIDDRC) Grant (U54 Eunice Kennedy Shriver National Institute of Child Health and Human Development, HD090216). The Confocal Imaging Facility, the Integrated Imaging Core, and the Transgenic and Gene Targeting Institutional Facility at the University of Kansas Medical Center are supported, in part, by NIH/NIGMS COBRE Grant P30GM122731 and by NIH/NICHD KIDDRC Grant U54HD090216.
Author contributions
J.P.G., D.G.I., E.G.H., N.R.W., A.C. and I.S. conceived and designed the experiments. J.P.G., E.G.H., E.K., N.R.W. and L.W.W. performed the experiments. D.G.I. and A.C. performed the time-lapse imaging analysis. J.P.G., Z.U. and A.Y. performed the manual cell-tracking. E.G.H., A.C. and I.S. wrote the paper. J.P.G., D.G.I., N.R.W. and L.W.W. edited the manuscript. All authors reviewed the manuscript.
Data availability
The live-imaging data that support the findings of this study are available from the corresponding authors upon reasonable request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Jeremy P. Goering, Dona G. Isai and Everett G. Hall.
Contributor Information
Andras Czirok, Email: aczirok@kumc.edu.
Irfan Saadi, Email: isaadi@kumc.edu.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-021-81123-9.
References
- 1.Bush JO, Jiang R. Palatogenesis: Morphogenetic and molecular mechanisms of secondary palate development. Development. 2012;139:231–243. doi: 10.1242/dev.067082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lan Y, Xu J, Jiang R. Cellular and molecular mechanisms of palatogenesis. Curr. Top. Dev. Biol. 2015;115:59–84. doi: 10.1016/bs.ctdb.2015.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Li C, Lan Y, Jiang R. Molecular and cellular mechanisms of palate development. J. Dent. Res. 2017;96:1184–1191. doi: 10.1177/0022034517703580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and palate. Lancet. 2009;374:1773–1785. doi: 10.1016/S0140-6736(09)60695-4. [DOI] [PubMed] [Google Scholar]
- 5.Jin JZ, et al. Mesenchymal cell remodeling during mouse secondary palate reorientation. Dev. Dyn. 2010;239:2110–2117. doi: 10.1002/dvdy.22339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yu K, Ornitz DM. Histomorphological study of palatal shelf elevation during murine secondary palate formation. Dev. Dyn. 2011;240:1737–1744. doi: 10.1002/dvdy.22670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Walker BE, Fraser FC. Closure of the secondary palate in three strains of mice. J. Embryol. Exp. Morphol. 1956;4:176–189. [Google Scholar]
- 8.Li C, Lan Y, Krumlauf R, Jiang R. Modulating Wnt signaling rescues palate morphogenesis in Pax9 mutant mice. J. Dent. Res. 2017;96:1273–1281. doi: 10.1177/0022034517719865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gritli-Linde A. The etiopathogenesis of cleft lip and cleft palate: Usefulness and caveats of mouse models. Curr. Top. Dev. Biol. 2008;84:37–138. doi: 10.1016/S0070-2153(08)00602-9. [DOI] [PubMed] [Google Scholar]
- 10.Jin JZ, Li Q, Higashi Y, Darling DS, Ding J. Analysis of Zfhx1a mutant mice reveals palatal shelf contact-independent medial edge epithelial differentiation during palate fusion. Cell Tissue Res. 2008;333:29–38. doi: 10.1007/s00441-008-0612-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kouskoura T, et al. The etiology of cleft palate formation in BMP7-deficient mice. PLoS ONE. 2013;8:e59463. doi: 10.1371/journal.pone.0059463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lan Y, Zhang N, Liu H, Xu J, Jiang R. Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. Development. 2016;143:2344–2355. doi: 10.1242/dev.134577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.He F, et al. Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development. Development. 2008;135:3871–3879. doi: 10.1242/dev.025767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Saadi I, et al. Deficiency of the cytoskeletal protein SPECC1L leads to oblique facial clefting. Am. J. Hum. Genet. 2011;89:44–55. doi: 10.1016/j.ajhg.2011.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bhoj EJ, et al. Phenotypic spectrum associated with SPECC1L pathogenic variants: New families and critical review of the nosology of Teebi, Opitz GBBB, and Baraitser-Winter syndromes. Eur. J. Med. Genet. 2018 doi: 10.1016/j.ejmg.2018.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bhoj EJ, et al. Expanding the SPECC1L mutation phenotypic spectrum to include Teebi hypertelorism syndrome. Am. J. Med. Genet. A. 2015;167A:2497–2502. doi: 10.1002/ajmg.a.37217. [DOI] [PubMed] [Google Scholar]
- 17.Kruszka P, et al. Mutations in SPECC1L, encoding sperm antigen with calponin homology and coiled-coil domains 1-like, are found in some cases of autosomal dominant Opitz G/BBB syndrome. J. Med. Genet. 2015;52:104–110. doi: 10.1136/jmedgenet-2014-102677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wilson NR, et al. SPECC1L deficiency results in increased adherens junction stability and reduced cranial neural crest cell delamination. Sci. Rep. 2016;6:17735. doi: 10.1038/srep17735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hall EG, et al. SPECC1L regulates palate development downstream of IRF6. Hum. Mol. Genet. 2020;29:845–858. doi: 10.1093/hmg/ddaa002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Neufeld Z, et al. The role of Allee effect in modelling post resection recurrence of glioblastoma. PLoS Comput. Biol. 2017;13:e1005818. doi: 10.1371/journal.pcbi.1005818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Czirok A, et al. Optical-flow based non-invasive analysis of cardiomyocyte contractility. Sci. Rep. 2017;7:10404. doi: 10.1038/s41598-017-10094-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zamir EA, Czirok A, Rongish BJ, Little CD. A digital image-based method for computational tissue fate mapping during early avian morphogenesis. Ann. Biomed. Eng. 2005;33:854–865. doi: 10.1007/s10439-005-3037-7. [DOI] [PubMed] [Google Scholar]
- 23.Gulyas M, Csiszer M, Mehes E, Czirok A. Software tools for cell culture-related 3D printed structures. PLoS ONE. 2018;13:e0203203. doi: 10.1371/journal.pone.0203203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Czirok A, Varga K, Mehes E, Szabo A. Collective cell streams in epithelial monolayers depend on cell adhesion. New J. Phys. 2013;15:75006. doi: 10.1088/1367-2630/15/7/075006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Szabo A, et al. Collective cell motion in endothelial monolayers. Phys. Biol. 2010;7:046007. doi: 10.1088/1478-3975/7/4/046007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Schindelin J, et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Das R, Kumar M, Mishra S. Order-disorder transition in active nematic: A lattice model study. Sci. Rep. 2017;7:7080. doi: 10.1038/s41598-017-07301-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Biggs LC, et al. Interferon regulatory factor 6 regulates keratinocyte migration. J. Cell Sci. 2014;127:2840–2848. doi: 10.1242/jcs.139246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Theveneau E, Mayor R. Collective cell migration of epithelial and mesenchymal cells. Cell Mol. Life Sci. 2013;70:3481–3492. doi: 10.1007/s00018-012-1251-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tang DD, Gerlach BD. The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration. Respir. Res. 2017;18:54. doi: 10.1186/s12931-017-0544-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Vasudevan HN, Mazot P, He F, Soriano P. Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways. Elife. 2015 doi: 10.7554/eLife.07186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Friedl P, Mayor R. Tuning collective cell migration by cell-cell junction regulation. Cold Spring Harb. Perspect. Biol. 2017 doi: 10.1101/cshperspect.a029199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Fallica B, Maffei JS, Villa S, Makin G, Zaman M. Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels. PLoS ONE. 2012;7:e48024. doi: 10.1371/journal.pone.0048024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zhang J, Yu XH, Yan YG, Wang C, Wang WJ. PI3K/Akt signaling in osteosarcoma. Clin. Chim. Acta. 2015;444:182–192. doi: 10.1016/j.cca.2014.12.041. [DOI] [PubMed] [Google Scholar]
- 35.Kuijjer ML, et al. Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy. BMC Med. Genomics. 2014;7:4. doi: 10.1186/1755-8794-7-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Chiquet M, Blumer S, Angelini M, Mitsiadis TA, Katsaros C. Mesenchymal remodeling during palatal shelf elevation revealed by extracellular matrix and F-actin expression patterns. Front. Physiol. 2016;7:392. doi: 10.3389/fphys.2016.00392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Fantauzzo KA, Soriano P. PI3K-mediated PDGFRalpha signaling regulates survival and proliferation in skeletal development through p53-dependent intracellular pathways. Genes Dev. 2014;28:1005–1017. doi: 10.1101/gad.238709.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Vasudevan HN, Soriano P. SRF regulates craniofacial development through selective recruitment of MRTF cofactors by PDGF signaling. Dev. Cell. 2014;31:332–344. doi: 10.1016/j.devcel.2014.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Gao L, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and TGFbeta3-mediated mouse embryonic palatal mesenchymal cells. Dose Response. 2019;17:1559325818786822. doi: 10.1177/1559325818786822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Iyyanar PPR, Nazarali AJ. Hoxa2 inhibits bone morphogenetic protein signaling during osteogenic differentiation of the palatal mesenchyme. Front. Physiol. 2017;8:929. doi: 10.3389/fphys.2017.00929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jiang Z, Pan L, Chen X, Chen Z, Xu D. Wnt6 influences the viability of mouse embryonic palatal mesenchymal cells via the beta-catenin pathway. Exp. Ther. Med. 2017;14:5339–5344. doi: 10.3892/etm.2017.5240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Liu X, et al. Negative interplay of retinoic acid and TGF-beta signaling mediated by TG-interacting factor to modulate mouse embryonic palate mesenchymal-cell proliferation. Birth Defects Res. B Dev. Reprod. Toxicol. 2014;101:403–409. doi: 10.1002/bdrb.21130. [DOI] [PubMed] [Google Scholar]
- 43.Fantauzzo KA, Soriano P. Generation of an immortalized mouse embryonic palatal mesenchyme cell line. PLoS ONE. 2017;12:e0179078. doi: 10.1371/journal.pone.0179078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.He F, Soriano P. A critical role for PDGFRalpha signaling in medial nasal process development. PLoS Genet. 2013;9:e1003851. doi: 10.1371/journal.pgen.1003851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Scarpa E, Mayor R. Collective cell migration in development. J. Cell Biol. 2016;212:143–155. doi: 10.1083/jcb.201508047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Liao Y, Hung MC. Physiological regulation of Akt activity and stability. Am. J. Transl. Res. 2010;2:19–42. [PMC free article] [PubMed] [Google Scholar]
- 47.Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655–1657. doi: 10.1126/science.296.5573.1655. [DOI] [PubMed] [Google Scholar]
- 48.Yang WL, Wu CY, Wu J, Lin HK. Regulation of Akt signaling activation by ubiquitination. Cell Cycle. 2010;9:487–497. doi: 10.4161/cc.9.3.10508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Guo J, Wei W. Fine-tuning AKT kinase activity through direct lysine methylation. Cell Cycle. 2019;18:917–922. doi: 10.1080/15384101.2019.1609832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Xue G, Hemmings BA. PKB/Akt-dependent regulation of cell motility. J. Natl. Cancer Inst. 2013;105:393–404. doi: 10.1093/jnci/djs648. [DOI] [PubMed] [Google Scholar]
- 51.Funato N, Nakamura M, Yanagisawa H. Molecular basis of cleft palates in mice. World J. Biol. Chem. 2015;6:121–138. doi: 10.4331/wjbc.v6.i3.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The live-imaging data that support the findings of this study are available from the corresponding authors upon reasonable request.